pharma · RSV Infection · NASH - Nonalcoholic Steatohepatitis · ENTA
ENANTA PHARMACEUTICALS
ENANTA PHARMACEUTICALS INC
ENANTA PHARMACEUTICALS clinical programs — 21 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 4 Kingsbury Ave, Watertown, Massachusetts 02472, US
- Founded
- 1995
- Employees
- 145
- Programs
- 34
- Drugs
- 15
- Patents
- 218
ENANTA PHARMACEUTICALS projects
21 ClinicalTrials.gov programs sponsored by ENANTA PHARMACEUTICALS.
ENANTA PHARMACEUTICALS has 21 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
DEB025
ENANTA PHARMACEUTICALS INC
Hepatitis C Virus
1 trial -
EDP 305
ENANTA PHARMACEUTICALS INC
NASH
1 trial -
EDP 305
ENANTA PHARMACEUTICALS INC
Presumptive NAFLD
1 trial -
EDP-235
ENANTA PHARMACEUTICALS INC
SARS CoV 2 Infection
1 trial -
EDP-297
ENANTA PHARMACEUTICALS INC
NASH - Nonalcoholic Steatohepatitis With Liver Fibrosis
1 trial -
EDP-305
ENANTA PHARMACEUTICALS INC
NASH - Nonalcoholic Steatohepatitis
2 trials -
EDP-322
ENANTA PHARMACEUTICALS INC
Skin and Soft Tissue Infections
1 trial -
EDP-322
ENANTA PHARMACEUTICALS INC
MRSA, SSTI
1 trial -
EDP-323
ENANTA PHARMACEUTICALS INC
RSV Infection
3 trials -
EDP-494
ENANTA PHARMACEUTICALS INC
Hepatitis C
1 trial -
EDP-514
ENANTA PHARMACEUTICALS INC
Chronic HBV Infection
2 trials -
EDP-514
ENANTA PHARMACEUTICALS INC
Hepatitis B
1 trial -
EDP-721
ENANTA PHARMACEUTICALS INC
Chronic Hepatitis B Virus Infection
1 trial -
EDP-788
ENANTA PHARMACEUTICALS INC
Safety in Normal Volunteers
1 trial -
EDP-788
ENANTA PHARMACEUTICALS INC
Healthy
1 trial -
EDP-978
ENANTA PHARMACEUTICALS INC
Chronic Inducible Urticaria
1 trial -
EDP239
ENANTA PHARMACEUTICALS INC
Hepatitis C
1 trial -
Fluconazole
ENANTA PHARMACEUTICALS INC
NASH - Nonalcoholic Steatohepatitis
1 trial -
Midazolam
ENANTA PHARMACEUTICALS INC
NASH
1 trial -
intraconazole
ENANTA PHARMACEUTICALS INC
NASH - Nonalcoholic Steatohepatitis
1 trial -
zelicapavir (therapeutic dose)
ENANTA PHARMACEUTICALS INC
RSV Infection
1 trial
Frequently asked questions
How many clinical projects does ENANTA PHARMACEUTICALS have?
21 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.